Auron Healthcare GmbH
🇩🇪Germany
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Auron Healthcare GmbH
- Target Recruit Count
- 73
- Registration Number
- NCT00405873
- Locations
- 🇩🇪
University Hospital Freiburg, Dept. of Internal Medicine II, Freiburg im Breisgau, Baaden-Wuerttemberg, Germany
🇩🇪Clinic SanaFontis, Freiburg im Breisgau, Germany
Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003
- First Posted Date
- 2006-11-30
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Auron Healthcare GmbH
- Target Recruit Count
- 67
- Registration Number
- NCT00405561
- Locations
- 🇩🇪
Clinic SanaFontis, Freiburg im Breisgau, Germany
Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo
Phase 2
Terminated
- Conditions
- Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
- Interventions
- First Posted Date
- 2006-06-01
- Last Posted Date
- 2013-03-20
- Lead Sponsor
- Auron Healthcare GmbH
- Target Recruit Count
- 67
- Registration Number
- NCT00332280
- Locations
- 🇧🇦
Klinicki Centar Univerziteta Sarajevo - Klinika za gastroenterohepatologiju, Sarajevo, Bosnia and Herzegovina
🇩🇪Clinic SanaFontis, Freiburg im Breisgau, Germany
News
No news found